Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-029968
Filing Date
2024-12-20
Accepted
2024-12-20 16:15:02
Documents
1
Period of Report
2024-12-18

Document Format Files

Seq Description Document Type Size
1 form4-12202024_091255.html 4  
1 form4-12202024_091255.xml 4 3154
  Complete submission text file 0001415889-24-029968.txt   4736
Mailing Address 5959 HORTON STREET, SUITE 300 EMERYVILLE CA 94608
Business Address 5959 HORTON STREET, SUITE 300 EMERYVILLE CA 94608 (510) 871-6100
Gritstone bio, Inc. (Issuer) CIK: 0001656634 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O KEZAR LIFE SCIENCES, INC. 4000 SHORELINE COURT, SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address
Economides Vassiliki (Reporting) CIK: 0001769674 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38663 | Film No.: 241568119